Study: Metformin helps pancreatic cancer patients with diabetes

04/5/2012 | DailyRx.com

A study in Clinical Cancer Research revealed that pancreatic cancer patients with diabetes who took metformin lived longer than those who did not take the drug. Researchers looked at 302 patients with both conditions and found that 30.1% of metformin-treated patients survived after two years, compared with 15.4% of those who did not receive metformin.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ